Innate Pharma
IPHA
$3.47
Share price
2.06%
Change (1 day)
-22.79%
Change (1 year)
Categories
Market capitalization of Innate Pharma (IPHA)
Market cap: NZ$0.29 Billion
As of March 2025 Innate Pharma has a market cap of NZ$0.29 Billion. This makes Innate Pharma the world's 8397th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Innate Pharma from 2006 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$0.29 B | -4.53% |
| 2024 | NZ$0.30 B | -14.9% |
| 2023 | NZ$0.36 B | -22.74% |
| 2022 | NZ$0.47 B | -19.65% |
| 2021 | NZ$0.58 B | 25.82% |
| 2020 | NZ$0.46 B | -40.34% |
| 2019 | NZ$0.78 B | -3.76% |
| 2018 | NZ$0.81 B | 77.02% |
| 2017 | NZ$0.45 B | -61.83% |
| 2016 | NZ$1.20 B | 3.21% |
| 2015 | NZ$1.16 B | 79.32% |
| 2014 | NZ$0.64 B | 70.39% |
| 2013 | NZ$0.38 B | 187.84% |
| 2012 | NZ$0.13 B | 100.76% |
| 2011 | NZ$65.92 M | -12.97% |
| 2010 | NZ$75.74 M | -57.63% |
| 2009 | NZ$0.17 B | 108.38% |
| 2008 | NZ$85.78 M | -28.48% |
| 2007 | NZ$0.11 B | -40.84% |
| 2006 | NZ$0.20 B |
End of Day market cap according to different sources
On Mar 30th, 2025 the market cap of Innate Pharma was reported to be:
